Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) INDUSTRY
2.1 Summary about Enzyme-Linked Immunosorbent Assay (ELISA) Industry
2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Market Trends
2.2.1 Enzyme-Linked Immunosorbent Assay (ELISA) Production & Consumption Trends
2.2.2 Enzyme-Linked Immunosorbent Assay (ELISA) Demand Structure Trends
2.3 Enzyme-Linked Immunosorbent Assay (ELISA) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Sandwich ELISA
4.2.2 Indirect ELISA
4.2.3 Competitive ELISA
4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Sandwich ELISA
4.3.2 Indirect ELISA
4.3.3 Competitive ELISA
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Sandwich ELISA
5.2.2 Indirect ELISA
5.2.3 Competitive ELISA
5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Sandwich ELISA
5.3.2 Indirect ELISA
5.3.3 Competitive ELISA
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Sandwich ELISA
6.2.2 Indirect ELISA
6.2.3 Competitive ELISA
6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Sandwich ELISA
6.3.2 Indirect ELISA
6.3.3 Competitive ELISA
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Sandwich ELISA
7.2.2 Indirect ELISA
7.2.3 Competitive ELISA
7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Sandwich ELISA
7.3.2 Indirect ELISA
7.3.3 Competitive ELISA
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Sandwich ELISA
8.2.2 Indirect ELISA
8.2.3 Competitive ELISA
8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Sandwich ELISA
8.3.2 Indirect ELISA
8.3.3 Competitive ELISA
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Sandwich ELISA
9.2.2 Indirect ELISA
9.2.3 Competitive ELISA
9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Sandwich ELISA
9.3.2 Indirect ELISA
9.3.3 Competitive ELISA
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 R&D Systems
10.1.2 Thermo Fisher Scientific
10.1.3 Ortho Clinical Diagnostics
10.1.4 BD Biosciences
10.1.5 ZEUS Scientific
10.1.6 Bio-Rad Laboratories
10.1.7 ALPCO
10.1.8 Enzo Life Sciences
10.1.9 BioMérieux
10.1.10 EMD Millipore
10.1.11 BioLegend
10.1.12 LOEWE Biochemica
10.1.13 Mercodia
10.1.14 Cusabio
10.1.15 Shanghai Kehua Bio-engineering
10.2 Enzyme-Linked Immunosorbent Assay (ELISA) Sales Date of Major Players (2017-2020e)
10.2.1 R&D Systems
10.2.2 Thermo Fisher Scientific
10.2.3 Ortho Clinical Diagnostics
10.2.4 BD Biosciences
10.2.5 ZEUS Scientific
10.2.6 Bio-Rad Laboratories
10.2.7 ALPCO
10.2.8 Enzo Life Sciences
10.2.9 BioMérieux
10.2.10 EMD Millipore
10.2.11 BioLegend
10.2.12 LOEWE Biochemica
10.2.13 Mercodia
10.2.14 Cusabio
10.2.15 Shanghai Kehua Bio-engineering
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
